Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dover Corporation stock logo
DOV
Dover
$172.06
-0.5%
$181.34
$143.04
$222.31
$23.60B1.271.04 million shs741,915 shs
Enovis Corporation stock logo
ENOV
Enovis
$32.35
+2.0%
$29.85
$25.47
$49.83
$1.85B1.681.17 million shs966,112 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$80.72
-2.5%
$93.48
$77.10
$163.71
$4.63B0.77929,268 shs1.21 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$176.16
-2.0%
$156.38
$55.92
$187.57
$5.66B1.1467,762 shs393,115 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dover Corporation stock logo
DOV
Dover
0.00%-2.59%-1.90%-3.62%-6.44%
Enovis Corporation stock logo
ENOV
Enovis
0.00%-0.92%+7.58%-1.40%-26.63%
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-11.73%-7.98%-17.53%-34.48%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%-0.68%+11.98%+24.18%+134.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dover Corporation stock logo
DOV
Dover
$172.06
-0.5%
$181.34
$143.04
$222.31
$23.60B1.271.04 million shs741,915 shs
Enovis Corporation stock logo
ENOV
Enovis
$32.35
+2.0%
$29.85
$25.47
$49.83
$1.85B1.681.17 million shs966,112 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$80.72
-2.5%
$93.48
$77.10
$163.71
$4.63B0.77929,268 shs1.21 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$176.16
-2.0%
$156.38
$55.92
$187.57
$5.66B1.1467,762 shs393,115 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dover Corporation stock logo
DOV
Dover
0.00%-2.59%-1.90%-3.62%-6.44%
Enovis Corporation stock logo
ENOV
Enovis
0.00%-0.92%+7.58%-1.40%-26.63%
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-11.73%-7.98%-17.53%-34.48%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%-0.68%+11.98%+24.18%+134.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dover Corporation stock logo
DOV
Dover
2.58
Moderate Buy$213.9224.33% Upside
Enovis Corporation stock logo
ENOV
Enovis
3.00
Buy$51.0057.65% Upside
Glaukos Corporation stock logo
GKOS
Glaukos
2.79
Moderate Buy$124.8354.65% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.00
Buy$163.82-7.01% Downside

Current Analyst Ratings Breakdown

Latest ENOV, DOV, IRTC, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2025
Glaukos Corporation stock logo
GKOS
Glaukos
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$118.00
8/28/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$180.00 ➝ $193.00
8/21/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$167.00 ➝ $183.00
8/20/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$200.00
8/15/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$70.00 ➝ $58.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$65.00 ➝ $57.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$48.00 ➝ $41.00
8/7/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$57.00 ➝ $49.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$145.00 ➝ $190.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dover Corporation stock logo
DOV
Dover
$7.83B3.01$10.79 per share15.95$50.69 per share3.39
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.88$19.61 per share1.65$45.10 per share0.72
Glaukos Corporation stock logo
GKOS
Glaukos
$432.95M10.69N/AN/A$13.91 per share5.80
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$591.84M9.56N/AN/A$2.90 per share60.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dover Corporation stock logo
DOV
Dover
$2.70B$16.5810.3816.721.3829.29%18.19%9.86%10/23/2025 (Estimated)
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$14.25N/A10.14N/A-37.80%6.78%3.73%11/5/2025 (Estimated)
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%11/3/2025 (Estimated)
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)

Latest ENOV, DOV, IRTC, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.79+$0.05-$0.64$555.80 million$564.50 million
7/31/2025Q2 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 million
7/24/2025Q2 2025
Dover Corporation stock logo
DOV
Dover
$2.39$2.44+$0.05$2.02$2.03 billion$2.05 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dover Corporation stock logo
DOV
Dover
$2.081.21%N/A12.55%70 Years
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A

Latest ENOV, DOV, IRTC, and GKOS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/8/2025
Dover Corporation stock logo
DOV
Dover
quarterly$0.521.16%8/29/20258/29/20259/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dover Corporation stock logo
DOV
Dover
0.36
1.95
1.35
Enovis Corporation stock logo
ENOV
Enovis
0.53
2.25
1.15
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
5.51
4.69
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
6.25
5.02
4.88

Institutional Ownership

CompanyInstitutional Ownership
Dover Corporation stock logo
DOV
Dover
84.46%
Enovis Corporation stock logo
ENOV
Enovis
98.45%
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A

Insider Ownership

CompanyInsider Ownership
Dover Corporation stock logo
DOV
Dover
1.30%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
Glaukos Corporation stock logo
GKOS
Glaukos
5.80%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dover Corporation stock logo
DOV
Dover
24,000137.13 million135.49 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.16 million55.62 millionOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.35 million53.68 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,00032.13 million31.91 millionOptionable

Recent News About These Companies

iRhythm Technologies $IRTC Shares Bought by Rhumbline Advisers
Amundi Trims Position in iRhythm Technologies $IRTC
Vident Advisory LLC Takes Position in iRhythm Technologies $IRTC

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Dover stock logo

Dover NYSE:DOV

$172.06 -0.92 (-0.53%)
Closing price 03:59 PM Eastern
Extended Trading
$172.00 -0.06 (-0.03%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.

Enovis stock logo

Enovis NYSE:ENOV

$32.35 +0.63 (+1.99%)
Closing price 03:59 PM Eastern
Extended Trading
$32.34 -0.01 (-0.03%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Glaukos stock logo

Glaukos NYSE:GKOS

$80.72 -2.04 (-2.46%)
Closing price 03:59 PM Eastern
Extended Trading
$82.60 +1.89 (+2.34%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$176.16 -3.66 (-2.04%)
Closing price 04:00 PM Eastern
Extended Trading
$176.16 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.